Menu
English
Stock Code: 00512.HK

Information Disclosure

Home
Information Disclosure

Contact Us

Units 3302, 33/F, The Center, 99 Queen's Road Central, Hong Kong

ir@chinagrandpharm.com

www.chinagrandpharm.com

Pages Links

Company Profile

Investor Relations

Legal Statement

Recent News

GP (HK) Announces 2020 Annual Results Profit Attributable to Owners of the Company Significantly Increase 55.8% to HK$1,792.7 million Technological Innovation Drives the Internationalization Planning Multiple Material Investment and M&A Projects Proceed Steadily

2021-3-19
SIR-Spheres® Y-90 Resin Microspheres Obtains Recommendation from NICE and Approval from the FDA to Conduct Clinical Trials on Primary Liver Cancer

2021-3-9

© 2021. China Grand Pharmaceutical and Healthcare Holdings Limited All Rights Reserved.